Patrick Kerney

Trusted by engineering leaders and government agencies to change the future of structural inspections. ConeLabs is an intelligent infrastructure inspection platform. We combine photogrammetry with proprietary AI to transform raw visual data into engineering-grade structural insights. Scale your workforce: Conduct inspections 70% faster—handling the repetitive data crunching so your inspectors can focus on high-value decision-making. Quantify Risk & Liability: Move from subjective visual checks to objective, data-driven Structural Health Monitoring (SHM) that integrates directly with your existing inspection workflows. Keeping a Human In the Loop: Empowering inspectors to verify, approve, or reject automated findings, ensuring you retain full authority over the data. Secure More Contracts: Win more projects and improve margins by offering complete, compliant, data-backed reporting that meets standards for infrastructure inspection. Why ConeLabs? We are not just a software company; we are led by structural engineers. Our intelligent platform is trained on verified structural datasets, ensuring high-fidelity defect quantification that stands up to regulatory scrutiny. All you need to provide are the images of the asset. Core Capabilities: Automated defect identification and classification Structural analysis Predictive defect propagation Intelligent reporting ConeLabs intelligently translates imagery data into final engineering reports. We empower asset managers and inspectors to prioritize repairs, optimize capital, and extend the lifespan of the built world with precision. Ready to deploy Engineering-Grade Intelligence? Reach out to sales@conelabs.ai for a demo

Cell and gene therapies, as well as viral vaccines, need higher production yields—and thats where we excel. We significantly increase yields by targeting the innate cellular defenses within production cells. These natural defenses, designed to combat foreign genetic material and inhibit viral replication, can hinder your process. Our solution is a unique panel small molecules which make up our Viral Sensitizer (VSETM) platform, which dampen cellular defenses. Using an innovative high-throughput screening process, we have developed a library of novel VSEs. Virica continues to leverage this advanced technology to pinpoint the most synergistic Viral Sensitizer molecules from our library, tailored to any virus or cell line. We customize formulations of these Viral Sensitizers to enhance virus yield in your manufacturing process or optimize the effectiveness of your viral therapies. The result is higher yields and improved quality, helping to reduce costs and improve patient access.

FORUS Therapeutics is a Canadian biopharmaceutical company dedicated to advancing differentiated, novel medicines for hematologic malignancies and other forms of cancer. Our mission is to bring health solutions to Canadian cancer patients, physicians, caregivers and the many partners and stakeholders that support them. Our goal is to accelerate unique and important treatments that meaningfully enhance life.

We are a grassroots soccer based founders group, committed to building a highly competitive womens professional soccer team thats backed by a passionate community of supporters in the GTA. More than a football club, we are building a field of dreams, empowerment and unlimited possibilities. We believe in the power of a simple ball to break barriers, unite hearts, and transform strangers into family. We exist to play a different game.

Trusted by engineering leaders and government agencies to change the future of structural inspections. ConeLabs is an intelligent infrastructure inspection platform. We combine photogrammetry with proprietary AI to transform raw visual data into engineering-grade structural insights. Scale your workforce: Conduct inspections 70% faster—handling the repetitive data crunching so your inspectors can focus on high-value decision-making. Quantify Risk & Liability: Move from subjective visual checks to objective, data-driven Structural Health Monitoring (SHM) that integrates directly with your existing inspection workflows. Keeping a Human In the Loop: Empowering inspectors to verify, approve, or reject automated findings, ensuring you retain full authority over the data. Secure More Contracts: Win more projects and improve margins by offering complete, compliant, data-backed reporting that meets standards for infrastructure inspection. Why ConeLabs? We are not just a software company; we are led by structural engineers. Our intelligent platform is trained on verified structural datasets, ensuring high-fidelity defect quantification that stands up to regulatory scrutiny. All you need to provide are the images of the asset. Core Capabilities: Automated defect identification and classification Structural analysis Predictive defect propagation Intelligent reporting ConeLabs intelligently translates imagery data into final engineering reports. We empower asset managers and inspectors to prioritize repairs, optimize capital, and extend the lifespan of the built world with precision. Ready to deploy Engineering-Grade Intelligence? Reach out to sales@conelabs.ai for a demo

Cell and gene therapies, as well as viral vaccines, need higher production yields—and thats where we excel. We significantly increase yields by targeting the innate cellular defenses within production cells. These natural defenses, designed to combat foreign genetic material and inhibit viral replication, can hinder your process. Our solution is a unique panel small molecules which make up our Viral Sensitizer (VSETM) platform, which dampen cellular defenses. Using an innovative high-throughput screening process, we have developed a library of novel VSEs. Virica continues to leverage this advanced technology to pinpoint the most synergistic Viral Sensitizer molecules from our library, tailored to any virus or cell line. We customize formulations of these Viral Sensitizers to enhance virus yield in your manufacturing process or optimize the effectiveness of your viral therapies. The result is higher yields and improved quality, helping to reduce costs and improve patient access.

FORUS Therapeutics is a Canadian biopharmaceutical company dedicated to advancing differentiated, novel medicines for hematologic malignancies and other forms of cancer. Our mission is to bring health solutions to Canadian cancer patients, physicians, caregivers and the many partners and stakeholders that support them. Our goal is to accelerate unique and important treatments that meaningfully enhance life.

We are a grassroots soccer based founders group, committed to building a highly competitive womens professional soccer team thats backed by a passionate community of supporters in the GTA. More than a football club, we are building a field of dreams, empowerment and unlimited possibilities. We believe in the power of a simple ball to break barriers, unite hearts, and transform strangers into family. We exist to play a different game.